Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine effects on striatal adenosine-dopamine interactions
NCT06763172Phase 4Recruiting
- Start
- May 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (2 arms). Primary endpoints: Dopamine D2/D3 receptor availability and Effects of caffeine on reinforcement learning assessed by Probabilistic Selection Task (PST). Started May 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06763172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06763172.